Literature DB >> 29222045

Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.

Rebecca Landy1, Li C Cheung2, Mark Schiffman2, Julia C Gage2, Noorie Hyun2, Nicolas Wentzensen2, Walter K Kinney3, Philip E Castle4, Barbara Fetterman5, Nancy E Poitras5, Thomas Lorey5, Peter D Sasieni6, Hormuzd A Katki2.   

Abstract

Electronic health-records (EHR) are increasingly used by epidemiologists studying disease following surveillance testing to provide evidence for screening intervals and referral guidelines. Although cost-effective, undiagnosed prevalent disease and interval censoring (in which asymptomatic disease is only observed at the time of testing) raise substantial analytic issues when estimating risk that cannot be addressed using Kaplan-Meier methods. Based on our experience analysing EHR from cervical cancer screening, we previously proposed the logistic-Weibull model to address these issues. Here we demonstrate how the choice of statistical method can impact risk estimates. We use observed data on 41,067 women in the cervical cancer screening program at Kaiser Permanente Northern California, 2003-2013, as well as simulations to evaluate the ability of different methods (Kaplan-Meier, Turnbull, Weibull and logistic-Weibull) to accurately estimate risk within a screening program. Cumulative risk estimates from the statistical methods varied considerably, with the largest differences occurring for prevalent disease risk when baseline disease ascertainment was random but incomplete. Kaplan-Meier underestimated risk at earlier times and overestimated risk at later times in the presence of interval censoring or undiagnosed prevalent disease. Turnbull performed well, though was inefficient and not smooth. The logistic-Weibull model performed well, except when event times didn't follow a Weibull distribution. We have demonstrated that methods for right-censored data, such as Kaplan-Meier, result in biased estimates of disease risks when applied to interval-censored data, such as screening programs using EHR data. The logistic-Weibull model is attractive, but the model fit must be checked against Turnbull non-parametric risk estimates.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervix; Electronic health-records; Epidemiology; Risk estimation; Screening; Statistical methods

Mesh:

Year:  2017        PMID: 29222045      PMCID: PMC5930038          DOI: 10.1016/j.ypmed.2017.12.004

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  8 in total

1.  Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.

Authors:  Megan A Clarke; Li C Cheung; Philip E Castle; Mark Schiffman; Diane Tokugawa; Nancy Poitras; Thomas Lorey; Walter Kinney; Nicolas Wentzensen
Journal:  JAMA Oncol       Date:  2019-02-01       Impact factor: 31.777

2.  The Improving Risk Informed HPV Screening (IRIS) Study: Design and Baseline Characteristics.

Authors:  Julia C Gage; Tina Raine-Bennett; Mark Schiffman; Megan A Clarke; Li C Cheung; Nancy E Poitras; Nicole E Varnado; Hormuzd A Katki; Philip E Castle; Brian Befano; Malini Chandra; Greg Rydzak; Thomas Lorey; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-17       Impact factor: 4.090

3.  Population-based e-records to evaluate HPV triage of screen-detected atypical squamous cervical lesions in Catalonia, Spain, 2010-15.

Authors:  Silvia de Sanjosé; Vanesa Rodríguez-Salés; Xavier F Bosch; Raquel Ibañez; Laia Bruni
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

4.  A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs.

Authors:  Maria Demarco; Noorie Hyun; Olivia Carter-Pokras; Tina R Raine-Bennett; Li Cheung; Xiaojian Chen; Anne Hammer; Nicole Campos; Walter Kinney; Julia C Gage; Brian Befano; Rebecca B Perkins; Xin He; Cher Dallal; Jie Chen; Nancy Poitras; Marie-Helene Mayrand; Francois Coutlee; Robert D Burk; Thomas Lorey; Philip E Castle; Nicolas Wentzensen; Mark Schiffman
Journal:  EClinicalMedicine       Date:  2020-04-25

Review 5.  Influential Usage of Big Data and Artificial Intelligence in Healthcare.

Authors:  Yan Cheng Yang; Saad Ul Islam; Asra Noor; Sadia Khan; Waseem Afsar; Shah Nazir
Journal:  Comput Math Methods Med       Date:  2021-09-06       Impact factor: 2.238

6.  2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation.

Authors:  Li C Cheung; Didem Egemen; Xiaojian Chen; Hormuzd A Katki; Maria Demarco; Amy L Wiser; Rebecca B Perkins; Richard S Guido; Nicolas Wentzensen; Mark Schiffman
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

7.  A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Authors:  Maria Demarco; Didem Egemen; Tina R Raine-Bennett; Li C Cheung; Brian Befano; Nancy E Poitras; Thomas S Lorey; Xiaojian Chen; Julia C Gage; Philip E Castle; Nicolas Wentzensen; Rebecca B Perkins; Richard S Guido; Mark Schiffman
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

8.  Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.

Authors:  Didem Egemen; Li C Cheung; Xiaojian Chen; Maria Demarco; Rebecca B Perkins; Walter Kinney; Nancy Poitras; Brian Befano; Alexander Locke; Richard S Guido; Amy L Wiser; Julia C Gage; Hormuzd A Katki; Nicolas Wentzensen; Philip E Castle; Mark Schiffman; Thomas S Lorey
Journal:  J Low Genit Tract Dis       Date:  2020-04       Impact factor: 3.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.